Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 33 (RPL29P33)

Target
RPL29P33
Molecular classification
Other (Processed pseudogene; not a protein-coding gene)
01

Overview

Ribosomal protein L29 pseudogene 33 (RPL29P33) is a non-coding processed pseudogene related to the ribosomal protein L29 gene (RPL29), which encodes a component of the large 60S ribosomal subunit responsible for protein synthesis in the cytoplasm. Pseudogenes like RPL29P33 arise from functional genes but have lost their protein-coding ability due to mutations and are typically transcriptionally inactive. There is no evidence that RPL29P33 encodes a protein, functions as a therapeutic target, or plays a role in disease. Multiple processed pseudogenes of ribosomal protein genes, including that of RPL29, are dispersed throughout the genome. Context: - The actual gene RPL29 encodes a structural ribosomal protein and plays a fundamental role in protein synthesis, with potential associations to diseases and cellular processes. - Pseudogenes, including RPL29P33, do not retain these functions and are typically not studied as molecular targets, drug-binding proteins, or disease markers. Summary note: RPL29P33 is not a valid therapeutic target or biomolecule for drug development. If you seek information on the functional protein, refer to "Ribosomal protein L29" (RPL29) instead.

Other names
RPL29P33RPL29 pseudogene 33

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 33 (RPL29P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 33 (RPL29P33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call